Nelnet Campus Commerce, a trusted leader in higher education payment technology, announced major product updates and roadmap advancements following its 2025 Virtual Client Summit, reinforcing the continued momentum of Project Horizon-the company's multi-year initiative to modernize campus payment solutions. More than 500 higher education professionals across the country attended the full-day virtual event on October […]

https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the “Class Period”), of the important December 15, 2025 lead plaintiff deadline. So what: If you purchased MoonLake common stockduring the Class Period

Elevate Holistics, a leading telehealth platform dedicated to expanding access to medically-recommended cannabis, today highlights compelling new findings from 2025 research that reinforce the therapeutic value of medical cannabis and align with the company's mission under the leadership of CEO Aspen Noonan. https://mma.prnewswire.com/media/1194826/Elevate_Holistics_Logo.jpg New 2025 Data Underscore Therapeutic Potential — According to a meta-analysis published

(NASDAQ:MLTX), SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that the MoonLake class action lawsuit – captioned Peters v. MoonLake Immunotherapeutics, No. 25-cv-08612 (S.D.N.Y.) – seeks to represent purchasers or acquirers of MoonLake Immunotherapeutics (NASDAQ: MLTX) common stock and charges MoonLake as well as

MLTX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire October 23, 2025 SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that the MoonLake class action lawsuit – captioned

(NASDAQ:FFIV), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In F5 (FFIV) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in F5 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at

F5 INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into F5, Inc. on Behalf of F5 Stockholders and Encourages Investors to Contact the Firm GlobeNewswire October 23, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In F5 (FFIV) To Contact Him Directly To Discuss Their Options If

(NASDAQ:ZION), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Zions (ZION) To Contact Him Directly To Discuss Their Options If you purchased or acquired Zions stock and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212)

ZIONS INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Zions and Urges Investors to Contact the Firm GlobeNewswire October 23, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Zions (ZION) To Contact Him Directly To Discuss Their Options If you purchased or acquired Zions stock

(NYSE:FCX), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Freeport (FCX) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Freeport and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at